The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
NCT05820048
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
Lansoprazole 15 mg
Sponsor
Daejeon St. Mary's hospital
Collaborators
[object Object]